索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张文斌,唐其柱,李金,等.半乳糖凝集素-3在心力衰竭中的研究进展[J].国际心血管病杂志,2015,05:320-322.
点击复制

半乳糖凝集素-3在心力衰竭中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年05期
页码:
320-322
栏目:
综述
出版日期:
2015-09-25

文章信息/Info

Title:
-
作者:
张文斌; 唐其柱; 李金; 向仕钊; 马振国
430060 武汉大学人民医院心内科
Author(s):
-
关键词:
半乳糖凝集素-3; 心力衰竭; 标志物
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2015.05.007
文献标识码:
-
摘要:
研究表明,半乳糖凝集素-3在心肌纤维化过程中发挥重要作用,与心力衰竭的发生、发展密切相关。该文就半乳糖凝集素-3在心力衰竭中的研究进行总结,为心力衰竭的诊治提供新的思路。
Abstract:
-

参考文献/References

[1] Sharma K, Kass DA.Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies[J].Circ Res,2014,115(1):79-96.
[2] González A, Ravassa S, Beaumont J,et al.New targets to treat the structural remodeling of the myocardium[J].J Am Coll Cardiol,2011,58(18):1833-1843.
[3] Coburn E, Frishman W.Comprehensive review of the prognostic value of galectin-3 in heart failure[J].Cardiol Rev,2014,22(4):171-175.
[4] Viguier M, Advedissian T, Delacour D,et al.Galectins in epithelial functions[J].Tissue Barriers,2014,2:e29103.
[5] Funasaka T, Raz A, Nangia-Makker P.Galectin-3 in angiogenesis and metastasis[J].Glycobiology,2014,24(10):886-891.
[6] Dumic J, Dabelic S, Flögel M.Galectin-3: an open-ended story[J].Biochim Biophys Acta, 2006,1760(4):616-635.
[7] Krzes'lak A, Lipińska A.Galectin-3 as a multifunctional protein[J].Cell Mol Biol Lett,2004,9(2):305-328.
[8] Jiang JX, Chen X, Hsu DK,et al.Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo[J].Am J Physiol Gastrointest Liver Physiol,2012,302(4):G439-G446.
[9] 朱雪峰,赵翠萍.心衰新标记物——半乳糖凝集素3 [J].国际心血管病杂志,2013,40(3):170-172.
[10] Stillman BN, Hsu DK, Pang M,et al.Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death[J].J Immunol,2006,176(2):778-789.
[11] Creemers EE, Pinto YM.Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart[J].Cardiovasc Res,2011,89(2):265-272.
[12] Ho JE, Liu C, Lyass A,et al.Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community[J].J Am Coll Cardiol,2012,60(14):1249-1256.
[13] Hrynchyshyn N, Jourdain P, Desnos M,et al.Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure[J].Arch Cardiovasc Dis,2013,106(10):541-546.
[14] de Boer RA, Yu L, van Veldhuisen DJ.Galectin-3 in cardiac remodeling and heart failure[J].Curr Heart Fail Rep,2010,7(1):1-8.
[15] Sharma UC, Pokharel S, van Brakel TJ,et al.Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction[J].Circulation,2004,110(19):3121-3128.
[16] Liu YH, D'Ambrosio M, Liao TD, et al. N-acetyl-serylaspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/ growth-regulatory lectin[J].Am J Physiol Heart Circ Physiol,2009,296(2):H404-H412.
[17] Chen K, Jiang RJ, Wang CQ, et al. Predictive value of plasma galectin-3 in patients with chronic heart failure [J].Eur Rev Med Pharmacol Sci, 2013, 17(8):1005-1011.
[18] Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices [J].J Heart Lung Transplant, 2008, 27(6):589-596.
[19] Lin YH, Lin LY, Wu YW, et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients[J]. Clin Chim Acta, 2009,409(1-2):96-99.
[20] van Kimmenade RR, Januzzi JL Jr, Ellinor PT, et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients withacute heart failure [J]. J Am Coll Cardiol, 2006, 48(6):1217-1224.
[21] 秦 月,仲 琳,杨 军.Galectin-3评估冠心病预后的临床价值[J].国际心血管病杂志,2015,42(3):207-211.
[22] de Boer RA, van Veldhuisen DJ, Gansevoort RT, et al. The fibrosis marker galectin-3 and outcome in the general population [J].J Intern Med, 2012, 272(1):55-64.
[23] Shah RV, Chen-Tournoux AA, Picard MH, et al. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure [J]. Eur J Heart Fail, 2010, 12(8):826-832.
[24] Lok DJ, Van Der Meer P, de la Porte PW, et al. Prognosticvalue of galectin-3, a novel marker of firosis, in patients with chronic heart failure: data from the DEAL-HF study [J].Clin Res Cardiol, 2010, 99(5):323-328.
[25] Hrynchyshyn N,Jourdain P, Desnos M, et al.Galectin-3:A new biomarker for the diagnosis,analysis and prognosis of acute and chronic heart failure [J].Arch Cardiovasc Dis, 2013, 106(10):541-546.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81270303) 作者单位:430060 武汉大学人民医院心内科 通信作者:唐其柱,Email:qztang@whu.edu.cn
更新日期/Last Update: 2015-10-20